Qalabka Warshada 4-Bromo-2-Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7

Si loo fuliyo qanacsanaanta macaamiisha, waxaan hadda haysanaa shaqaalaheena xooggan si aan u bixino kaalmadayada guud ee ugu weyn oo ay ku jirto kor u qaadida, iibinta guud, qorsheynta, abuurista, kontoroolka tayada sare, baakadaha, bakhaarada iyo saadka ee Supply Warshada 4-Bromo-2 -Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7, Waxaan nahay daacad oo furan.Waxaan rajaynaynaa booqashadaada iyo samaynta xiriir la aamini karo oo waqti dheer ah.
Si loo fuliyo qanacsanaanta macaamiisha, waxaan hadda haysanaa shaqaalaheena xooggan si aan u bixino kaalmadayada guud ee ugu weyn oo ay ku jirto kor u qaadida, iibinta guud, qorsheynta, abuurista, kontoroolka tayada sare leh, baakad, bakhaar iyo saadkaShiinaha CAS 112704-79-7 iyo 112704-79-7, Alaabtayadu waxay ku guuleysteen sumcad aad u wanaagsan mid kasta oo ka mid ah quruumaha la xiriira.Sababtoo ah aasaaska shirkadeena.Waxaan ku adkaysanay hal-abuurnimada habraacayaga wax-soo-saarka oo ay weheliso hab-maamuleedka casriga ah ee ugu dambeeyay, anagoo soo jiidannay tiro badan oo karti ah gudaha warshadahan.Waxaan u aragnaa xalka tayada wanaagsan inuu yahay dabeecadeena nuxurka ugu muhiimsan.

1-Bromo-2-methoxy-3-nitro-benzene waxaa loo isticmaalaa dhexdhexaadinta Eltrombopag.
Eltrombopag, oo ay soo saartay GlaxoSmithKline (GSK) ee UK oo markii dambe si wadajir ah ula sameeyay Novartis ee Switzerland, waa kan ugu horreeya oo kaliya ee la ansixiyay molecule yar yar oo aan peptide TPO receptor agonist ee adduunka.Eltrombopag waxaa ansixiyay US FDA 2008 si loogu daweeyo idiopathic thrombocytopenic purpura (ITP), iyo 2014 ee daawaynta aplastic anemia daran (AA).Sidoo kale waa dawadii ugu horeysay ee ay ogolaato FDA US daawaynta AA 30kii sano ee la soo dhaafay.
Bishii Disembar 2012, US FDA waxay ansixisay Eltrombopag daaweynta thrombocytopenia ee bukaannada qaba cagaarshow C dabadheeraad ah (CHC), si bukaannada cagaarshowga C ee qaba saadaasha liidata sababtoo ah tirinta platelet hoose waxay bilaabi karaan oo ay ilaalin karaan interferon ku salaysan daaweynta caadiga ah ee cudurada beerka.Febraayo 3,2014, GlaxoSmithKline waxay ku dhawaaqday in FDA ay siisay shahaadada daawaynta dawaynta ee Eltrombopag ee daawaynta hemopenia ee bukaanada qaba buuga kiimikada daran aplastic anemia (SAA) kuwaas oo aan si buuxda uga jawaabin tallaalka.Agoosto 24, 2015, US FDA waxay ansixisay Eltrombopag daawaynta thrombocytopenia ee dadka waaweyn iyo carruurta da'doodu tahay 1 sano iyo ka weyn ee leh difaaca joogtada ah ee thrombocytopenia (ITP) kuwaas oo aan lahayn jawaab celin ku filan corticosteroids, immunoglobulins ama splenectomy.Janaayo 4, 2018, Eltrombopag waxaa loo ogolaaday in lagu daro Shiinaha si loogu daaweeyo trombocytopenia difaaca aasaasiga ah (ITP).

Si loo fuliyo qanacsanaanta macaamiisha, waxaan hadda haysanaa shaqaalaheena xooggan si aan u bixino kaalmadayada guud ee ugu weyn oo ay ku jirto kor u qaadida, iibinta guud, qorsheynta, abuurista, kontoroolka tayada sare, baakadaha, bakhaarada iyo saadka ee Supply Warshada 4-Bromo-2 -Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7, Waxaan nahay daacad oo furan.Waxaan rajaynaynaa booqashadaada iyo samaynta xiriir la aamini karo oo waqti dheer ah.
Qalabka WarshadaShiinaha CAS 112704-79-7 iyo 112704-79-7, Alaabtayadu waxay ku guuleysteen sumcad aad u wanaagsan mid kasta oo ka mid ah quruumaha la xiriira.Sababtoo ah aasaaska shirkadeena.Waxaan ku adkaysanay hal-abuurnimada habraacayaga wax-soo-saarka oo ay weheliso hab-maamuleedka casriga ah ee ugu dambeeyay, anagoo soo jiidannay tiro badan oo karti ah gudaha warshadahan.Waxaan u aragnaa xalka tayada wanaagsan inuu yahay dabeecadeena nuxurka ugu muhiimsan.